151 related articles for article (PubMed ID: 1353684)
1. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs.
Bongers J; Lambros T; Ahmad M; Heimer EP
Biochim Biophys Acta; 1992 Jul; 1122(2):147-53. PubMed ID: 1353684
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase IV (DPP-IV) from pig kidney cleaves analogs of bovine growth hormone-releasing factor (bGRF) modified at position 2 with Ser, Thr or Val. Extended DPP-IV substrate specificity?
Martin RA; Cleary DL; Guido DM; Zurcher-Neely HA; Kubiak TM
Biochim Biophys Acta; 1993 Aug; 1164(3):252-60. PubMed ID: 8102071
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of mouse growth hormone-releasing factor, mGRF(1-42)OH, and selected analogs from the bovine GRF series in mouse and bovine plasma in vitro.
Kubiak TM; Martin RA; Leone JW; Cleary DL
Pept Res; 1994; 7(3):153-61. PubMed ID: 7915920
[TBL] [Abstract][Full Text] [Related]
4. Position 2 and position 2/Ala15-substituted analogs of bovine growth hormone-releasing factor (bGRF) with enhanced metabolic stability and improved in vivo bioactivity.
Kubiak TM; Friedman AR; Martin RA; Ichhpurani AK; Alaniz GR; Claflin WH; Goodwin MC; Cleary DL; Kelly CR; Hillman RM
J Med Chem; 1993 Apr; 36(7):888-97. PubMed ID: 8464043
[TBL] [Abstract][Full Text] [Related]
5. Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7).
Maes MB; Lambeir AM; Gilany K; Senten K; Van der Veken P; Leiting B; Augustyns K; Scharpé S; De Meester I
Biochem J; 2005 Mar; 386(Pt 2):315-24. PubMed ID: 15487984
[TBL] [Abstract][Full Text] [Related]
6. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor.
Bongers J; Heimer EP; Lambros T; Pan YC; Campbell RM; Felix AM
Int J Pept Protein Res; 1992 Apr; 39(4):364-74. PubMed ID: 1428526
[TBL] [Abstract][Full Text] [Related]
7. The involvement of dipeptidyl peptidase IV in brush-border degradation of GRF(1-29)NH2 by intestinal mucosal cells.
Bai JP; Chang LL
J Pharm Pharmacol; 1995 Aug; 47(8):698-701. PubMed ID: 8583376
[TBL] [Abstract][Full Text] [Related]
8. In vitro metabolic degradation of a bovine growth hormone-releasing factor analog Leu27-bGRF(1-29)NH2 in bovine and porcine plasma. Correlation with plasma dipeptidylpeptidase activity.
Kubiak TM; Kelly CR; Krabill LF
Drug Metab Dispos; 1989; 17(4):393-7. PubMed ID: 2571478
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of novel C-terminal-extended and biotinylated growth hormone-releasing factor (GRF) analogs.
Campbell RM; Lee Y; Mowles TF; McIntyre KW; Ahmad M; Felix AM; Heimer EP
Peptides; 1992; 13(4):787-93. PubMed ID: 1437717
[TBL] [Abstract][Full Text] [Related]
10. In vitro stability of growth hormone releasing factor (GRF) analogs in porcine plasma.
Su CM; Jensen LR; Heimer EP; Felix AM; Pan YC; Mowles TF
Horm Metab Res; 1991 Jan; 23(1):15-21. PubMed ID: 1826667
[TBL] [Abstract][Full Text] [Related]
11. Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences.
Campbell RM; Stricker P; Miller R; Bongers J; Liu W; Lambros T; Ahmad M; Felix AM; Heimer EP
Peptides; 1994; 15(3):489-95. PubMed ID: 7937325
[TBL] [Abstract][Full Text] [Related]
12. Are diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu) inhibitors or substrates of dipeptidyl peptidase IV?
Rahfeld J; Schierhorn M; Hartrodt B; Neubert K; Heins J
Biochim Biophys Acta; 1991 Jan; 1076(2):314-6. PubMed ID: 1671823
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone-releasing factor analogs with hydrophobic residues at position 19. Effects on growth hormone releasing activity in vitro and in vivo, stability in blood plasma in vitro, and secondary structure.
Friedman AR; Ichhpurani AK; Moseley WM; Alaniz GR; Claflin WH; Cleary DL; Prairie MD; Krueger WC; Frohman LA; Downs TR
J Med Chem; 1992 Oct; 35(21):3928-33. PubMed ID: 1433201
[TBL] [Abstract][Full Text] [Related]
14. The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta.
Nausch I; Mentlein R; Heymann E
Biol Chem Hoppe Seyler; 1990 Nov; 371(11):1113-8. PubMed ID: 1982212
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma.
Frohman LA; Downs TR; Heimer EP; Felix AM
J Clin Invest; 1989 May; 83(5):1533-40. PubMed ID: 2565342
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of proline-specific proteinases: (I) Substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum.
Heins J; Welker P; Schönlein C; Born I; Hartrodt B; Neubert K; Tsuru D; Barth A
Biochim Biophys Acta; 1988 May; 954(2):161-9. PubMed ID: 2896517
[TBL] [Abstract][Full Text] [Related]
17. Stepwise degradation of the hexapeptide Met-Ala-Ser-Pro-Phe-Ala by dipeptidyl peptidase IV.
Berger E; Fischer G; Neubert K; Barth A
Biomed Biochim Acta; 1987; 46(10):671-6. PubMed ID: 2895640
[TBL] [Abstract][Full Text] [Related]
18. Comparison of enzymatic semisyntheses of peptide amides: human growth hormone releasing factor and analogs.
Bongers J; Offord RE; Felix AM; Lambros T; Liu W; Ahmad M; Campbell RM; Heimer EP
Biomed Biochim Acta; 1991; 50(10-11):S157-62. PubMed ID: 1820039
[TBL] [Abstract][Full Text] [Related]
19. Identification of serine 624, aspartic acid 702, and histidine 734 as the catalytic triad residues of mouse dipeptidyl-peptidase IV (CD26). A member of a novel family of nonclassical serine hydrolases.
David F; Bernard AM; Pierres M; Marguet D
J Biol Chem; 1993 Aug; 268(23):17247-52. PubMed ID: 8102366
[TBL] [Abstract][Full Text] [Related]
20. Depth of side-chain pocket in the S2 subsite of dipeptidyl peptidase IV.
Harada M; Fukasawa K; Hiraoka BY; Mogi M; Barth A; Neubert K
Biochim Biophys Acta; 1985 Aug; 830(3):341-4. PubMed ID: 2862917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
